Cytisinicline significantly increases quit rates in smokers with or without COPD while being safe and well tolerated.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The 2024 GOLD report newly highlights hyperinflation, ...

Achieve recently announced that the FDA accepted its cytisinicline New Drug Application for treatment of nicotine dependence for smoking cessation, with a PDUFA target action date of June 20, 2026.

Researchers noted that the relationships between smoking, chronic obstructive pulmonary disease (COPD), and depression must be recognized to effectively manage the complicated care needs for this ...

Theory-based smoking cessation interventions helped to motivate patients with chronic obstructive pulmonary disease (COPD) who smoke to quit, ultimately improving their quality of life and lung ...

C hronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition—primarily chronic bronchitis and ...

Achieve Life Sciences (ACHV) announced the publication of new data in Thorax demonstrating that cytisinicline significantly improved smoking quit ...

Veterans with COPD and current tobacco use faced a reduced likelihood for tobacco dependence treatment if they lived in a ...

Credit: Getty Images. The 2024 GOLD COPD Report includes updated research and recommendations that reflect shifts in thinking on COPD management. Vogelmeier, who heads the Department of Medicine, ...

It is estimated that 49.2 million adults in the United States use tobacco products. Cigarettes are the most commonly used tobacco product, followed by electronic cigarettes. According to the Centers ...

In a population spirometric screening of 11,027 subjects who were at risk for COPD in 12 Polish cities, AL was detected in 30.6% of smokers who were > 39 years of age who had a smoking history of > 10 ...